Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of oral treosulfan in advanced pre-treated Ewing's sarcoma
2005-003254-10Phase 2Completed
- Sponsor
- University College London
- Start
- May 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of treosulfan in Ewing sarcoma of bone, sponsored by University College London. Primary endpoint: Objective response rate (ORR). Started May 2009; status: completed.
02
Drugs
treosulfan
03
Conditions
Ewing sarcoma of bone
Beyond the preview
Go deeper on 2005-003254-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003254-10.